Mindy Hamlin

It has been a good run lately for Shengmin Sang, Ph.D. Sang, associate professor and lead scientist in the Center for Excellence in Post-Harvest Technologies ​at North Carolina Agricultural and Technical State University labs in Kannapolis, was awarded the inaugural Innovation for Impact Grand Prize Thursday night in Greensboro. The award was among those presented at Triad BioNight, a celebration of bioscience leadership in the Piedmont Triad region. MORE COVERAGE: Award details plus other Triad BioNight winners WTW Insider bonus: Who is Dr. Shengmin Sang? Read his full bio The award competition, co-sponsored by SoBran Bioscience and the Piedmont...

This week at the CED Life Science Conference, Mark McClellan, M.D., director of the Duke-Margolis Center for Health Policy, discussed healthcare reform and biomedical innovation. They are topics he is uniquely qualified to tackle, as the former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration. Throughout his presentation, McClellan returned to the themes of sustainable healthcare reforms for better outcomes, value-based payment in healthcare and the need for better real-world evidence of treatment success. Following are some highlights. Status of the Affordable Care Act In his presentation, McClellan...

Entrepreneurs seeking investors in their companies heard from four corporate venture capital funds at the CED Life Science Conference panel, “Follow the Money,” earlier this week. Venture capitalists from Lilly Ventures, J&J Development Corp., Novo Ventures and Illumina Ventures discussed what their funds and parent companies are looking for in investment partners. While each of the funds has its own strategic direction, they all agreed that their funds invest in innovative companies that will be strong partners. According to Steve Hall of Lilly Ventures, the fund’s focus is on identifying “paradigm shifting therapies” that can strengthen and support Lilly...